A comprehensive scientific review led by researchers in Argentina has suggested that intermittent fasting may deliver minimal impact on weight reduction among adults living with overweight or obesity. The study, conducted by specialists from the Hospital Universitario Italiano de Buenos Aires, evaluated existing clinical trials to determine whether the popular dietary approach offers measurable advantages over conventional nutritional guidance.
Intermittent fasting has gained considerable global attention in recent years as an alternative weight management strategy. The practice typically involves structured eating windows, fasting on selected days, or alternating between normal food intake and periods of significant calorie restriction. One widely recognised variation, known as the “5:2 diet”, encourages individuals to substantially reduce calorie consumption on two non-consecutive days each week.
Evidence from International Clinical Studies
The review analysed results from 22 previously published studies involving nearly 2,000 participants. Researchers compared short-term intermittent fasting programmes, lasting up to 12 months, with traditional dietary recommendations focused on calorie reduction and balanced nutrition, as well as scenarios where no structured guidance was provided.
The principal conclusion indicated that intermittent fasting appears to produce little or no significant improvement in weight loss outcomes or overall quality of life when compared with standard nutritional strategies. The findings were published in the Cochrane Database of Systematic Reviews, a widely recognised source of evidence-based medical research.
Although the authors acknowledged that intermittent fasting might contribute to general health improvements through potential physiological adaptations, they emphasised that current scientific data remains inconclusive. Additional studies are therefore required to confirm whether metabolic or systemic health benefits are consistently associated with the practice.
Concerns Regarding Public Perception
Lead researcher Luis Garegnani expressed concern about the rapid growth of online content promoting intermittent fasting as a highly effective weight-loss method. He noted that, while fasting regimens may be suitable for certain individuals, current scientific evidence does not fully support the level of popularity observed across digital platforms.
Supporting this perspective, Baptiste Leurent, a medical statistics specialist at University College London in United Kingdom, stated that collective findings from the analysed studies consistently demonstrate limited measurable benefits. According to him, the widespread promotion of intermittent fasting represents a broader gap between public perception and scientific validation.
Similarly, Keith Frayn, professor emeritus of human metabolism at the University of Oxford, highlighted that intermittent fasting is often marketed as producing unique metabolic advantages. However, he emphasised that available evidence suggests these claims may not hold significant clinical relevance, reinforcing the importance of sustained calorie control as the primary evidence-based method for weight management.
Individual Variability and Clinical Recommendations
Researchers involved in the review stressed that responses to dietary interventions can vary substantially between individuals. Eva Madrid, senior author of the analysis, explained that healthcare professionals should adopt personalised treatment plans when advising patients with excess body weight.
Experts also noted methodological limitations in several of the analysed trials. Many studies included relatively small participant groups and did not consistently apply the most rigorous clinical research techniques. These factors reduce statistical strength and limit the ability to generalise findings across broader populations.
Future Directions for Research
The review highlighted the need for further scientific investigation into the potential effects of intermittent fasting on chronic conditions, including type 2 diabetes and other metabolic disorders. Researchers also indicated that future studies should examine how fasting strategies influence different demographic groups, including variations between men and women, individuals with diverse body mass index ranges, and populations from multiple regions.
The clinical trials assessed in the review were conducted across Europe, North America, China, Australia and South America, demonstrating the global interest in intermittent fasting as a public health topic. While some observational research has suggested that fasting may assist in reducing cholesterol levels, blood glucose and supporting gut health, scientists emphasise that these outcomes require stronger, long-term clinical validation.
As dietary trends continue to circulate widely through digital media, healthcare specialists reinforce that sustainable lifestyle modifications — including balanced nutrition and consistent physical activity — remain the most reliable strategies for long-term weight control and overall health improvement.